Journal of Neurology

, 254:1221 | Cite as

The role of hereditary spastic paraplegia related genes in multiple sclerosis

A study of disease susceptibility and clinical outcome
  • G. C. DeLuca
  • S. V. Ramagopalan
  • M. Z. Cader
  • D. A. Dyment
  • B. M. Herrera
  • S. Orton
  • A. Degenhardt
  • M. Pugliatti
  • A. D. Sadovnick
  • S. Sotgiu
  • G. C. Ebers
ORIGINAL COMMUNICATION

Abstract

Multiple sclerosis (MS) is a common inflammatory disease of the central nervous system unsurpassed for its variability in disease outcome. It has been observed that axonal loss in MS is significant and that irreversible clinical disability relates to such axonal loss. The clinical similarities between Hereditary Spastic Paraplegia (HSP) and progressive MS, along with their analogous profiles of axonal loss in the long tracts, make the genes known to cause HSP biologically relevant candidates for the study of clinical outcome in MS. A cohort of sporadic MS cases and a set of unaffected controls were used to determine the role of HSP genes on MS susceptibility and disease severity. The MS cases were taken from opposite extremes of the putative distribution of long-term outcome using the most stringent clinical criteria to date. Genotyping the two sets of MS patients and controls could not provide any evidence to suggest that genes involved in the pathogenesis of HSP (Paraplegin, NIPA1, KIF5A, HSPD1, Atlastin, Spartin, Spastin, PLP1, L1CAM, Maspardin and BSCL2) play a role in susceptibility to, or modifying the course of, MS, although small effects of these genes cannot be ruled out.

Key words

multiple sclerosis genetics 

References

  1. 1.
    Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. [see comment]. N Engl J Med 343:1430–1438CrossRefPubMedGoogle Scholar
  2. 2.
    Confavreux C, Vukusic S, Adeleine P (2003) Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.[ see comment]. Brain 126:770–782CrossRefPubMedGoogle Scholar
  3. 3.
    Ebers GC (2001) Natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 71 (Suppl 2):ii16–ii19PubMedGoogle Scholar
  4. 4.
    DeLuca GC, Ebers GC, Esiri MM (2004) Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 127:1009–1018CrossRefPubMedGoogle Scholar
  5. 5.
    McAlpine D, Lumsden CE, Acheson ED (1972) Multiple sclerosis: a reappraisal. Churchill Livingstone, EdinburghGoogle Scholar
  6. 6.
    Bergers E, Bot JC, De Groot CJ, Polman CH, Lycklama a Nijeholt GJ, Castelijns JA, van der Valk P, Barkhof F (2002) Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology 59:1766–1771PubMedGoogle Scholar
  7. 7.
    Bjartmar C, Kinkel RP, Kidd G, Rudick RA, Trapp BD (2001) Axonal loss in normal-appearing white matter in a patient with acute MS. Neurology 57:1248–1252PubMedGoogle Scholar
  8. 8.
    Iannucci G, Minicucci L, Rodegher M, Sormani MP, Comi G, Filippi M (1999) Correlations between clinical and MRI involvement in multiple sclerosis: assessment using T(1), T(2) and MT histograms. J Neurol Sci 171:121–129CrossRefPubMedGoogle Scholar
  9. 9.
    Mainero C, De Stefano N, Iannucci G, Sormani MP, Guidi L, Federico A, Bartolozzi ML, Comi G, Filippi M (2001) Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology 56:1331–1334PubMedGoogle Scholar
  10. 10.
    Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lucking CH (1998) Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. [see comment]. J Neurol Neurosurg Psychiatry 65:822–827CrossRefPubMedGoogle Scholar
  11. 11.
    Said G, Marion MH, Selva J, Jamet C (1986) Hypotrophic and dying-back nerve fibers in Friedreich’s ataxia. Neurology 36:1292–1299PubMedGoogle Scholar
  12. 12.
    Jitpimolmard S, Small J, King RH, Geddes J, Misra P, McLaughlin J, Muddle JR, Cole M, Harding AE, Thomas PK (1993) The sensory neuropathy of Friedreich’s ataxia: an autopsy study of a case with prolonged survival. Acta Neuropathol 86:29–35CrossRefPubMedGoogle Scholar
  13. 13.
    Behan WM, Maia M (1974) Strumpell’s familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry 37:8–20CrossRefPubMedGoogle Scholar
  14. 14.
    DeLuca GC, Ebers GC, Esiri MM (2004) The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol 30:576–584CrossRefPubMedGoogle Scholar
  15. 15.
    Crosby AH, Proukakis C (2002) Is the transportation highway the right road for hereditary spastic paraplegia? [comment]. Am J Hum Genet 71:1009–1016CrossRefPubMedGoogle Scholar
  16. 16.
    Griffin JW, Watson DF (1988) Axonal transport in neurological disease. Ann Neurol 23:3–13CrossRefPubMedGoogle Scholar
  17. 17.
    Kantarci OH, de Andrade M, Weinshenker BG (2002) Identifying disease modifying genes in multiple sclerosis. J Neuroimmunol 123:144–159CrossRefPubMedGoogle Scholar
  18. 18.
    Kenealy SJ, Pericak-Vance MA, Haines JL (2003) The genetic epidemiology of multiple sclerosis. J Neuroimmunol 143:7–12CrossRefPubMedGoogle Scholar
  19. 19.
    Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, McDonald WI, Miller DH (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. [see comment] [erratum appears in Brain 1996 Aug; 119(Pt 4):1415]. Brain 118:1583–1592CrossRefPubMedGoogle Scholar
  20. 20.
    Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD (2002) Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 61:23–32PubMedGoogle Scholar
  21. 21.
    Fink JK, Heiman-Patterson T, Bird T, Cambi F, Dube MP, Figlewicz DA, Haines JL, Hentati A, Pericak-Vance MA, Raskind W, Rouleau GA, Siddique T (1996) Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology 46:1507–1514PubMedGoogle Scholar
  22. 22.
    Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 1:1151–1155CrossRefPubMedGoogle Scholar
  23. 23.
    Kremenchutzky M, Cottrell D, Rice G, Hader W, Baskerville J, Koopman W, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation. Brain 122 (Pt 10):1941–1950CrossRefPubMedGoogle Scholar
  24. 24.
    Reid E (1999) The hereditary spastic paraplegias. J Neurol 246:995–1003CrossRefPubMedGoogle Scholar
  25. 25.
    Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi MMX, De Sa J (1997) Primary progressive multiple sclerosis. Brain 120(Pt 6):1085–1096CrossRefPubMedGoogle Scholar
  26. 26.
    Fink JK (2003) The hereditary spastic paraplegias: nine genes and counting. Arch Neurol 60:1045–1049CrossRefPubMedGoogle Scholar
  27. 27.
    Risch N, Zhang H (1995) Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 268:1584–1589CrossRefPubMedGoogle Scholar
  28. 28.
    Sadovnick AD, Risch NJ, Ebers GC (1998) Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 25:216–221PubMedGoogle Scholar
  29. 29.
    D’Alfonso S, Nistico L, Zavattari P, Marrosu MG, Murru R, Lai M, Massacesi L, Ballerini C, Gestri D, Salvetti M, Ristori G, Bomprezzi R, Trojano M, Liguori M, Gambi D, Quattrone A, Fruci D, Cucca F, Richiardi PM, Tosi R (1999) Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families. Eur J Hum Genet 7:377–385CrossRefPubMedGoogle Scholar
  30. 30.
    Ban M, Stewart GJ, Bennetts BH, Heard R, Simmons R, Maranian M, Compston A, Sawcer SJ (2002) A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun 3:464–469CrossRefPubMedGoogle Scholar
  31. 31.
    Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A (1996) A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 13:464–468CrossRefPubMedGoogle Scholar
  32. 32.
    Broadley S, Sawcer S, D’Alfonso S, Hensiek A, Coraddu F, Gray J, Roxburgh R, Clayton D, Buttinelli C, Quattrone A, Trojano M, Massacesi L, Compston A (2001) A genome screen for multiple sclerosis in Italian families. Genes Immun 2:205–210CrossRefPubMedGoogle Scholar
  33. 33.
    Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRefPubMedGoogle Scholar
  34. 34.
    Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229CrossRefPubMedGoogle Scholar
  35. 35.
    Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, Scotti G, Comi G (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45:478–482PubMedGoogle Scholar
  36. 36.
    Losseff NA, Webb SL, O’Riordan JI, Page R, Wang L, Barker GJ, Tofts PS, McDonald WI, Miller DH, Thompson AJ (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119:701–708CrossRefPubMedGoogle Scholar
  37. 37.
    Ebers GC, Sadovnick AD (1994) The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 54:1–7CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff-Verlag 2007

Authors and Affiliations

  • G. C. DeLuca
    • 1
    • 2
  • S. V. Ramagopalan
    • 1
    • 2
  • M. Z. Cader
    • 1
    • 2
  • D. A. Dyment
    • 1
    • 2
  • B. M. Herrera
    • 1
    • 2
  • S. Orton
    • 1
    • 2
  • A. Degenhardt
    • 1
  • M. Pugliatti
    • 4
  • A. D. Sadovnick
    • 3
  • S. Sotgiu
    • 4
  • G. C. Ebers
    • 1
    • 2
  1. 1.University Dept. of Clinical NeurologyUniversity of Oxford, Radcliffe InfirmaryOxfordUK
  2. 2.Wellcome Trust Centre for Human GeneticsUniversity of OxfordOxfordUK
  3. 3.Dept. of Medical Genetics and Faculty of Medicine, Division of NeurologyUniversity of British ColumbiaVancouverCanada
  4. 4.Institute of Clinical NeurologyUniversity of SassariSassariItaly

Personalised recommendations